Glaucoma News

NASHVILLE, Tenn. — Patients who underwent MIGS procedures with and without phacoemulsification experienced IOP reductions and low complication rates, according to data from the IRIS Registry.

Sub-Tenon injection of mitomycin C may be an alternative to conventional application of MMC with sponges, according to a study.

NASHVILLE, Tenn. — Patients with glaucoma who underwent trabeculectomy or tube shunt surgery had similar rates of reoperation and similar surgical outcomes regardless of initial procedure, according to a study.

PHILADELPHIA — Developments in OCT imaging offer ophthalmologists a look into the future of glaucoma progression management, according to a speaker here.

NASHVILLE, Tenn. — It is important to use all of the tools available to diagnose glaucoma progression, according to a presentation at the American Glaucoma Society meeting.

In this episode I share my top 5 predictions in ophthalmology for 2022, including my thoughts on the future of COVID-19 and ocular gene therapy.

To celebrate the 40th anniversary of Healio/Ocular Surgery News, the Associate Medical Editors are sharing what they think are the most important ophthalmic innovations of the 2010s.

SAN FRANCISCO — In this video from Glaucoma 360 New Horizons Forum, Thurein Htoo, MS, MBA, CEO of Qlaris Bio, discusses the importance of lowering episcleral venous pressure, or EVP.

NASHVILLE, Tenn. — When treating a patient with glaucoma, surgeons should take steps to anticipate and avoid problems related to unwanted blood, according to an expert.

NASHVILLE, Tenn. — At the American Glaucoma Society meeting, Osamah Saeedi, MD, discusses results from a study exploring the effect of Rhopressa (netarsudil ophthalmic solution 0.02%, Aerie Pharmaceuticals) on episcleral venous flow rates.